4) γ-glutamyl cysteine synthetase(γ-GCS)
γ-谷氨酰半胱氨酸甘氨酸合成酶
6) γ-glutamylcysteine synthetase
γ-谷氨酰半胱氨酸合酶
1.
Objective To explore the mechanism of traditional Chinese medicine(TCM) treatment according to syndrome differentiation in treating chronic obstructive pulmonary disease(COPD) by observing the changes of nuclear factor-κB(NF-κB) and γ-glutamylcysteine synthetase(γ-GCS) expression levels in rats.
目的通过观察慢性阻塞性肺疾病(COPD)大鼠核因子κB和γ-谷氨酰半胱氨酸合酶(γ-GCS)水平的变化,探讨中医药治疗COPD的机理。
2.
Objective To explore the regulation of peroxisome proliferator-activated receptor γ coactivator 1α(PGC-1α) and NF-E2-related factor 2(Nrf2) on expression of γ-glutamylcysteine synthetase(γ-GCS),and their roles in chronic obstructive pulmonary disease(COPD).
目的探讨过氧化物酶体增殖物激活受体γ辅激活因子1α(PGC-1α)和红系衍生的核因子相关因子2(Nrf2)对γ-谷氨酰半胱氨酸合酶(γ-GCS)表达的调控及其在COPD中的作用和意义。
补充资料：5-L-谷氨酰-L-半胱氨酰甘氨酸
分子式：C10H17N3O6S
分子量：307.32
CAS号：70-18-8
性质：熔点182-192°C。比旋光度-16.5° (c=2, H2O)。水溶性soluble。
分子量：307.32
CAS号：70-18-8
性质：熔点182-192°C。比旋光度-16.5° (c=2, H2O)。水溶性soluble。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条